Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

payer survey

- PMLiVE

Researchers suggest delaying second dose of Pfizer/BioNTech jab to protect more people

Canada-based researchers Skowronski and De Serres say first dose is ‘highly protective’

- PMLiVE

Henry Skinner has been appointed as the first CEO of the AMR Action Fund

The AMR Action Fund is aiming to strengthen and accelerate antibiotic development

- PMLiVE

Don’t hesitate, vaccinate!

Different communities may have different questions or information needs about COVID-19 vaccination

- PMLiVE

Richest countries are on course to purchase one billion excess COVID-19 vaccines, new analysis finds

Report from the ONE Campaign considered vaccine supply deals agreed by G20 countries and the EU

- PMLiVE

Novavax to provide 1.1 billion COVID-19 vaccine doses to COVAX

Memorandum of understanding announced between Novavax, Gavi and the Vaccine Alliance

- PMLiVE

AMR Action Fund raises $140m from new investors to tackle antimicrobial resistance

New investment adds to initial $1bn raised at the Fund's launch last year

Risk Management, Ethics, and Compliance Considerations in the New Normal

Myriam Prescott, Head of Ethics, Risks and Compliance - Oncology, Novartis Canada, dissects the importance of effective patient engagement and strong compliance & monitoring programs. We also dive into the...

Impetus Digital

A Deep-Dive into the COVID-19 Pandemic and its Secondary Effects

Dr. Farah Fourcand, Author of Pandemic Manifesto, shares her experience working on the frontlines of the COVID-19 pandemic. She also dives into the psychological impact of COVID-19, lessons learned from the...

Impetus Digital

- PMLiVE

Lilly signs $960m deal with Rigel to develop RIPK1 inhibitors

Companies will co-develop molecules for the treatment of immunological and neurodegenerative diseases

- PMLiVE

10 Top Tips to Optimise Your Virtual Conference

A virtual conference is a live digital event, built around an agenda to replicate an in-person event. In this blog, Digital Engagement Manager Laura Smith shares her 10 top tips...

IGNIFI

- PMLiVE

AZ/Merck & Co’s PARP inhibitor Lynparza scores trial win in early breast cancer

Trial halted early after crossing superiority boundary for the primary endpoint of invasive disease-free survival

EU flag

Pfizer/BioNTech and Moderna increase COVID-19 vaccine supplies to the EU

The EU now currently has access to 2.6 billion COVID-19 vaccine doses from a range of companies

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links